Article
Deep learning framework for predicting EGFR mutation status from H&E whole slide images in lung adenocarcinoma.
BMC cancer - 1 Apr 2026
Shao Weiwei, Gu Wenyue, Song Shu, Chen Danyi, Shao Zhongming, Sun Qian, Yu Hong
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) mutations are pivotal molecular drivers in lung adenocarcinoma (LUAD) with significant therapeutic implications, yet conventional molecular testing remains costly, time-consuming, and limited by tissue availability. This study aimed to develop and validate a pathology-based predictive model that integrates deep learning and machine learning to identify EGFR...
Topics
Join the communities discussing this publication.
